ArticlePloS one2013

Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors.

Takeshi Harada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.